Table 3.
Treatments and clinical outcomes in 116 patients with Chlamydia psittaci pneumonia
| Variables | All patients (N = 116) |
Non severe group (N = 63) |
Severe group (N = 53) |
p values (< 0.050) |
Survive group (N = 43) |
None survive group (N = 10) |
p values (< 0.050) |
|---|---|---|---|---|---|---|---|
| Respiratory support | |||||||
| Oxygen | 41 (35.3%) | 34 (54.0%) | 7 (13.2%) | < 0.001 | 6 (14.0%) | 1 (10.0%) | 0.739 |
| High-flow nasal cannula | 9 (7.8%) | 4 (6.3%) | 5 (9.4%) | 0.536 | 5 (11.6%) | 0 (0%) | 0.257 |
| Non-invasive ventilation | 8 (6.9%) | 0 (0%) | 8 (15.1%) | 0.001 | 5 (11.6%) | 3 (30.0%) | 0.144 |
| Invasive ventilation | 21 (18.1%) | 0 (0%) | 21 (39.6%) | < 0.001 | 14 (32.6%) | 7 (70.0%) | 0.029 |
| Respiratory therapy except oxygen | 31 (26.7%) | 4 (5.6%) | 27 (60.0%) | < 0.001 | 19 (44.2%) | 8 (80.0%) | 0.041 |
| Other supportive treatment | |||||||
| CRRT | 4 (3.4%) | 0 (0%) | 4 (7.5%) | 0.026 | 2 (4.7%) | 2 (20.0%) | 0.098 |
| ECMO | 2 (1.7%) | 0 (0%) | 2 (3.8%) | 0.120 | 1 (2.3%) | 1 (10.0%) | 0.251 |
| Length of stay | |||||||
| Hospital day | 14.0 (10.0–17.0) | 14.0 (8.0–14.0) | 14.0 (14.0–20.0) | < 0.001 | 14.0 (14.0–19.5) | 13.5 (8.4) | 0.112 |
| ICU day | 0.0 (0.0–4.0) | 0.0 (0.0–0.0) | 3.0 (0.0–14.0) | < 0.001 | 0.0 (0.0–12.0) | 10.2 (8.2) | 0.032 |
| Outcomes | |||||||
| Death | 10 (8.6%) | 0 (0%) | 10 (18.9%) | < 0.001 | 0 (0%) | 10 (100.0%) | < 0.001 |
| ICU | 58 (50.0%) | 15 (23.8%) | 43 (81.1%) | < 0.001 | 34 (79.1%) | 9 (90.0%) | 0.426 |
| Survive | 106 (91.4%) | 63(100%) | 43(81%) | < 0.001 | 43 | 0 (0%) | < 0.001 |
Values are numbers (percentages) or median (IQR) unless stated otherwise. Percentages do not total to 100% owing to missing data